PT - JOURNAL ARTICLE AU - Najmul Haider AU - Abdinasir Yusuf Osman AU - Audrey Gadzekpo AU - George O. Akpede AU - Danny Asogun AU - Rashid Ansumana AU - Richard Lessells AU - Palwasha Khan AU - Muzamil Mahdi Abdel Hamid AU - Dorothy Yeboah-Manu AU - Leonard Mboera AU - Elizabeth H Shayo AU - Blandina T Mbaga AU - Mark Urassa AU - David Musoke AU - Nathan Kapata AU - Rashida Abbas Ferrand AU - Pascalina Chanda-Kapata AU - Florian Stigler AU - Thomas Czypionka AU - Richard Kock AU - David McCoy TI - Lockdown measures in response to COVID-19 in Sub-Saharan Africa: A rapid study of nine countries AID - 10.1101/2020.07.09.20149054 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.09.20149054 4099 - http://medrxiv.org/content/early/2020/07/11/2020.07.09.20149054.short 4100 - http://medrxiv.org/content/early/2020/07/11/2020.07.09.20149054.full AB - Lockdown measures have been introduced worldwide to contain the transmission of COVID-19. This paper defines the term lockdown and describes the design, timing and implementation of lockdown in nine countries in Sub Saharan Africa: Ghana, Nigeria, South Africa, Sierra Leone, Sudan, Tanzania, Uganda, Zambia and Zimbabwe. It also discusses the manner in which lockdown is enforced, the need to mitigate the harms of lockdown, and the association between lockdown and the reported number of COVID-19 cases and deaths. While there are some commonalities in the implementation of lockdown, a more notable finding is the variation in the design, timing and implementation of lockdown measures across the nine countries. We found that the number of reported cases is heavily dependent on the number of tests done, and that testing rates ranged from 9 to 21,261 per million population. The reported number of COVID-19 deaths per million population also varies, but is generally low when compared to countries in Europe and North America. While lockdown measures may have helped inhibit some community transmission, the pattern and nature of the epidemic remains unclear. Of concern are signs of lockdown harming health by affecting the functioning of the health system and causing social and economic harms. This paper highlights the need for inter-sectoral and trans-disciplinary research capable of providing a rigorous and holistic assessment of the harms and benefits of lockdown.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementWe received no fund for this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study does not contain any personal level data and thus exempted from IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data presented in this article are publicly available (e.g. Worldometer, World Bank, WHO etc.). For further details please contact the corresponding author: d.mccoy{at}qmul.ac.uk